Table 1 Demographic characteristics of enrolled participants in this study

Age (years)

38 (30–45)

38 (34–43)

38(32–42)

38(31–43)

0.910^a

CD4⁺ T (cells/µL)

348 (154–468)

295 (282–327)

976 (719–1148)

820 (517–1080)

0.000^a

CD8⁺ T (cells/µL)

1021 (649–1136)

808 (495–1014)

1059 (760–1346)

806 (705–953)

0.227^a

CD4/CD8 ratio

0.41 (0.15–0.50)

0.43 (0.30–0.51)

1.06 (0.65–1.40)

1.07(0.76–1.46)

0.000^a

Viral load (log₁₀ copies/mL)

4.21 (3.76–4.67)

<LDL

<LDL

-

-

ART time (years)

6.1 (4–8)

6.6 (5-8.3)

-

0.531^b

ART regimen (%)

AZT/3TC/EFV

-

2 (10%)

6 (30%)

-

0.236^c

TDF/3TC/EFV

-

14 (70%)

13 (65%)

-

1.000^d

TDF/3TC/DTG

2 (10%)

0

0.468^c

TAF/FTC/DTG

-

2 (10%)

1 (5%)

-

1.000^c